Trinity Biotech PLC (FRA:TRB)
€ 2.12 0 (0%) Market Cap: 20.08 Mil Enterprise Value: 78.95 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 52/100

Q4 2020 Trinity Biotech PLC Earnings Call Transcript

Mar 25, 2021 / 03:00PM GMT
Release Date Price: €15.8 (-11.73%)
Operator

Good day, and welcome to the Trinity Biotech Q4 and Fiscal Year 2020 Financial Results Conference Call. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Mr. Ronan OâCaoimh. Please go ahead.

Ronan Oâ;Caoimh
Trinity Biotech plc - Chairman & CEO

Thank you very much. Good afternoon here, and good morning to everybody in the United States. I'm joined by John Gillard, our Chief Financial Officer, and who is firstly going to bring you through the results for the quarter. Then I'm going to give you an outline of progress in sales and marketing, and I'll give you a revenue review, and then we'll open the call to a question-and-answer session.

So if I could ask John to go ahead, please.

John Gillard
Trinity Biotech plc - CFO & Director

Thanks, Ronan. Good morning, everyone, or afternoon, depending on where you are at. And thank you for participating in our earnings conference call.

Before we begin, I must

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot